Lipum AB: Lipum gets approval to start Phase 1 clinical trial with drug candidate SOL-116

Press release: Umeå, 27 September, 2022. Lipum AB (publ) announces today that the CTA (clinical trial application) for the drug candidate SOL-116 has been approved by the regulatory authorities in The Netherlands.The study that includes healthy volunteers and patients with rheumatoid arthritis will be carried out at QPS BV facility in Groningen, Netherlands. The study [...]

2022-10-05T11:55:06+02:00

Lipum has resolved on a directed share issue of approximately SEK 39 million at a subscription price of SEK 14.99 per share

Press release: Umeå, September 22, 2022. The Board of Directors of Lipum AB (publ) (“Lipum” or the “Company”) has resolved on a directed issue of 2,601,732 shares at a subscription price of SEK 14.99 per share to Flerie Invest AB and certain other existing and new investors with pronounced long-term interests in the Company (the [...]

2022-10-05T11:55:06+02:00

Lipum to participate in upcoming industry meetings

News: Umeå, 9 August 2022.  Lipum (publ), a biopharmaceutical company focused on chronic inflammatory diseases, today announced its participation in the following upcoming conferences.LSX Nordic, Copenhagen, Denmark, 6-7 September              Biostock Investerarevent, digital, 14 September Nordic Life Science Days, Malmö, Sweden, 28-29 September Bio-Europe, Leipzig, Germany, 24-26 October Redeye Life Science Day, Stockholm, Sweden, 24 [...]

2022-10-05T11:55:06+02:00

Lipum AB: Lipum to participate in upcoming industry meetings

News: Umeå, 9 August 2022.  Lipum (publ), a biopharmaceutical company focused on chronic inflammatory diseases, today announced its participation in the following upcoming conferences.LSX Nordic (https://www.lsxleaders.com/lsx-nordic-congress), Copenhagen, Denmark, 6-7 September             Biostock Investerarevent, (https://www.biostock.se/2022/02/biostock-investor-meeting-14-september/) digital, 14 SeptemberNordic Life Science Days, (https://www.nlsdays.com/) Malmö, Sweden, 28-29 SeptemberBio-Europe, (https://informaconnect.com/bioeurope/?utm_source=iito.de&utm_medium=referral&utm_campaign=EBEU2020ViitoB&utm_term=GeneralBanners&utm_content=EBEU2020ViitoB&tracker_id=EBEU2020ViitoB) Leipzig, Germany, 24-26 OctoberRedeye Life Science Day (https://www.redeye.se/company/lipum?searchResult=028bb6d5-cc54-3998-aae5-945113c4cb2b&query=lipum&fromPage=FULL), Stockholm, Sweden, 24 NovemberBiostock Life Science Summit (https://www.biostock.se/en/2022/01/biostock-life-science-summit-2022/), [...]

2022-10-05T11:48:05+02:00

Lipum AB – interim report for the period January – June 2021

Press release: Umeå, 27 July, 2022. Lipum AB has published the interim report for period January to June 2022. Below is a short summary, a complete report (only in Swedish) is available on the company's website (https://lipum.se/finansiella-rapporter/).CEO Einar Pontén comments: “Through long-term and systematic work, we are now almost ready to start clinical trials. We have [...]

2022-10-05T11:55:06+02:00

Lipum AB – interim report for the period January – June 2021

Press release: Umeå, 27 July, 2022. Lipum AB has published the interim report for period January to June 2022. Below is a short summary, a complete report (only in Swedish) is available on the company's website (https://lipum.se/finansiella-rapporter/).CEO Einar Pontén comments: "Through long-term and systematic work, we are now almost ready to start clinical trials. We have [...]

2022-10-05T11:48:05+02:00

Lipum AB: Lipum has recruited Helena Bergström as Chief Medical Officer

News: Umeå, 8 July, 2022. Lipum (publ) is preparing for the start of its first in human phase 1 clinical trial and the team is now strengthened with Dr. Helena Bergström that has been recruited as chief medical officer (CMO).Dr. Helena Bergström is an experienced clinician that previously also has been involved in research of [...]

2022-10-05T11:48:05+02:00

Lipum AB: Lipum participates at Redeye Growth Day 2022

News: Umeå, 25 May 2022. In June, Lipum will present at Redeye Growth Day, EULAR 2022, Biostock Life Science Summit Spring and Aktiespararnas Småbolagsdag.Redeye Growth Day (https://www.redeye.se/events/833514/redeye-growth-day-2022) takes place on June 2 in Stockholm and will be a combination of a digital platform and live presentations. Lipum is "In Focus" at 11:20, link (https://redeye.ifairs.com/#/lobby) to the event.Lipum [...]

2022-05-25T11:30:00+02:00

Lipum AB – interim report for the period January-March 2022

Press release: Umeå, 18 May 2022. Lipum AB (publ) has published the interim report for period January to March for 2022. Below is a summary, a complete report (only in Swedish) is available on the company's website (https://lipum.se/finansiella-rapporter/).CEO Einar Pontén comments: "More progress was made in the preparations ahead of clinical trials. In parallel, and in [...]

2022-05-18T08:30:00+02:00
Till toppen